Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Comparison of Oct4, Sox2 and Nanog Expression in Pancreatic Cancer Cell Lines and Human Pancreatic Tumor

Vahideh Assadollahi 1 , Mohammadreza Gholami 1 , Abolfazl Zendedel 2 , * , Zohreh Afsartala 1 and Ferdoos Jahanmardi 3
Authors Information
1 Department of Anatomy, Lorestan University of Medical Sciences, Khorramabad, IR Iran
2 Department of Internist, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, IR Iran
3 Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: December 2015, 17 (12); e5186
  • Published Online: December 26, 2015
  • Article Type: Research Article
  • Received: July 12, 2014
  • Accepted: November 24, 2014
  • DOI: 10.17795/zjrms-5186

To Cite: Assadollahi V, Gholami M, Zendedel A, Afsartala Z, Jahanmardi F. Comparison of Oct4, Sox2 and Nanog Expression in Pancreatic Cancer Cell Lines and Human Pancreatic Tumor, Zahedan J Res Med Sci. 2015 ; 17(12):e5186. doi: 10.17795/zjrms-5186.

Abstract
Copyright © 2015, Zahedan University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859): 105-11[DOI][PubMed]
  • 2. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006; 355(12): 1253-61[DOI][PubMed]
  • 3. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003; 3(12): 895-902[DOI][PubMed]
  • 4. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea--a paradigm shift. Cancer Res. 2006; 66(4): 1883-90[DOI][PubMed]
  • 5. Sagar J, Chaib B, Sales K, Winslet M, Seifalian A. Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int. 2007; 7: 9[DOI][PubMed]
  • 6. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1): 10-29[DOI][PubMed]
  • 7. Castellanos E, Berlin J, Cardin DB. Current treatment options for pancreatic carcinoma. Curr Oncol Rep. 2011; 13(3): 195-205[DOI][PubMed]
  • 8. Costello E, Neoptolemos JP. Pancreatic cancer in 2010: new insights for early intervention and detection. Nat Rev Gastroenterol Hepatol. 2011; 8(2): 71-3[DOI][PubMed]
  • 9. Kim EJ, Simeone DM. Advances in pancreatic cancer. Curr Opin Gastroenterol. 2011; 27(5): 460-6[DOI][PubMed]
  • 10. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004; 23(43): 7274-82[DOI][PubMed]
  • 11. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005; 5(4): 275-84[DOI][PubMed]
  • 12. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature. 1990; 344(6265): 435-9[DOI][PubMed]
  • 13. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells. 2001; 19(4): 271-8[DOI][PubMed]
  • 14. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003; 63(9): 2244-50[PubMed]
  • 15. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer. 2004; 101(9): 2006-10[DOI][PubMed]
  • 16. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003; 113(5): 643-55[PubMed]
  • 17. Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A, et al. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development. 2004; 131(15): 3805-19[DOI][PubMed]
  • 18. Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural progenitor identity. Neuron. 2003; 39(5): 749-65[PubMed]
  • 19. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, et al. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer. 2011; 104(9): 1410-7[DOI][PubMed]
  • 20. Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, Muller F, et al. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer. 2011; 11: 42[DOI][PubMed]
  • 21. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells. 2009; 27(1): 40-8[DOI][PubMed]
  • 22. Freberg CT, Dahl JA, Timoskainen S, Collas P. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell. 2007; 18(5): 1543-53[DOI][PubMed]
  • 23. Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 2005; 104(10): 2255-65[DOI][PubMed]
  • 24. Avery S, Inniss K, Moore H. The regulation of self-renewal in human embryonic stem cells. Stem Cells Dev. 2006; 15(5): 729-40[DOI][PubMed]
  • 25. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH, et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem. 2005; 280(26): 24731-7[DOI][PubMed]
  • 26. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008; 40(5): 499-507[DOI][PubMed]
  • 27. Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun. 2009; 383(2): 157-62[DOI][PubMed]
  • 28. Gostjeva EV, Thilly WG. Stem cell stages and the origins of colon cancer: a multidisciplinary perspective. Stem Cell Rev. 2005; 1(3): 243-51[DOI][PubMed]
  • 29. Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell. 2006; 124(6): 1111-5[DOI][PubMed]
  • 30. Haraguchi N, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Sasaki A, et al. Cancer stem cells in human gastrointestinal cancers. Hum Cell. 2006; 19(1): 24-9[DOI][PubMed]
  • 31. Amini S, Fathi F, Parivar K, Kuchesfahani HM, Rezaie MJ, Nikkhoo B. Evaluating the expression of Oct4, NANOG, Sox2 and nucleostemin in colon cancer cell lines (Caco-2 and HT-29). Yakhteh Med J. 2010; 12(2): 223-30
  • 32. Saheli M, Hosseini A, Piryaei A, Fadaei Fathabadi F, Bandehpour M, Salehi M, et al. Evaluation of the differentiation process of human bone marrow mesenchymal stem cells to cardiomyocyte-like cells: An in vitro study. J Iran Anat Sci. 2011; 9(36): 179-90
  • 33. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005; 26(2): 495-502[DOI][PubMed]
  • 34. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer. 2007; 120(7): 1598-602[DOI][PubMed]
  • 35. Amini S, Fathi F, Mobalegi J, Sofimajidpour H, Ghadimi T. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat Cell Biol. 2014; 47(1): 1-11[DOI][PubMed]
  • 36. Liu N, Lu M, Tian X, Han Z. Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells. J Cell Physiol. 2007; 211(2): 279-86[DOI][PubMed]
  • 37. Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 2004; 23(43): 7150-60[DOI][PubMed]
  • 38. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004; 4(8): 653-71[PubMed]
  • 39. Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, et al. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res. 2012; 174(1): 130-5[DOI][PubMed]
  • 40. Schulz WA, Hoffmann MJ. Transcription factor networks in embryonic stem cells and testicular cancer and the definition of epigenetics. Epigenetics. 2007; 2(1): 37-42[PubMed]
  • 41. Herreros-Villanueva M, Zhang JS, Koenig A, Abel EV, Smyrk TC, Bamlet WR, et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis. 2013; 2[DOI][PubMed]
  • 42. Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X, et al. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett. 2013; 340(1): 113-23[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments